Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis

Abstract

BackgroundMycoplasma genitalium is a common cause of non-gonococcal non-chlamydial urethritis and cervicitis. Testing of asymptomatic populations has been proposed, but prevalence in asymptomatic populations is not well established. We aimed to estimate the prevalence of M. genitalium in the general population, pregnant women, men who have sex with men (MSM), commercial sex workers (CSWs) and clinic-based samples.MethodsWe searched Embase, Medline, IndMED, African Index Medicus and LILACS from 1 January 1991 to 12 July 2016 without language restrictions. We included studies with 500 participants or more. Two reviewers independently screened and selected studies and extracted data. We examined forest plots and conducted random-effects meta-analysis to estimate prevalence, if appropriate. Between-study heterogeneity was examined using the I2 statistic and meta-regression.ResultsOf 3316 screened records, 63 were included. In randomly selected samples from the general population, the summary prevalence was 1.3% (95% CI 1.0% to 1.8%, I2 41.5%, three studies, 9091 people) in countries with higher levels of development and 3.9% (95% CI 2.2 to 6.7, I2 89.2%, three studies, 3809 people) in countries with lower levels. Prevalence was similar in women and men (P=0.47). In clinic based samples, prevalence estimates were higher, except in asymptomatic patients (0.8%, 95% CI 0.4 to 1.4, I2 0.0%, three studies, 2889 people). Summary prevalence estimates were, in the following groups: pregnant women 0.9% (95% CI 0.6% to 1.4%, I2 0%, four studies, 3472 people), MSM in the community 3.2% (95% CI 2.1 to 5.1, I2 78.3%, five studies, 3012 people) and female CSWs in the community 15.9% (95% CI 13.5 to 18.9, I2 79.9%, four studies, 4006 people).DiscussionThis systematic review can inform testing guidelines for M. genitalium. The low estimated prevalence of M. genitalium in the general population, pregnant women and asymptomatic attenders at clinics does not support expansion of testing to these groups.Registration numbersPROSPERO: CRD42015020420

De novo mutations drive the spread of macrolide-resistant Mycoplasma genitalium: a mathematical modelling study

“…We set the natural clearance rate γ to 0.8 y -1 , a published estimate based on epidemiological data and mathematical modelling [30], and the infection rate ,β, to 0.816 person -1 y -1 . These values result in an equilibrium prevalence of M. genitalium infections of about 2% in the absence of any treatment, which is consistent with estimates of the prevalence of M. genitalium in the sexually active population in high-income countries [31,32]. The values for the natural clearance rate and the prevalence of infection do not govern the relative growth rate of the drug-resistant proportion (Equation 6), so they do not influence the relative prevalence of resistant infections or estimates of the treatment rate in our model.…”

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland

“…The global estimate for the prevalence of M. genitalium is 1.7% in under 25-year-old women [29], that is slightly lower than the global prevalence of 3.8% for C. trachomatis in 15-49-year-old-women [2]. In our study, M. genitalium DNA was detected in 3.2% of the specimens, approximately as often as C. trachomatis [16].…”

Mycoplasma genitalium: the next sexually transmitted superbug?

“…Data on population prevalence are sparse, but a meta-analysis of six studies suggested that the prevalence of M genitalium infection ranged from 1.3% to 3.9% and was higher in countries with a low development index 11. In Britain, a probability sample survey estimated a prevalence of around 1.3% in the sexually active British population aged 16-44 years 4.…”

“…In Britain, a probability sample survey estimated a prevalence of around 1.3% in the sexually active British population aged 16-44 years 4. In common with many other sexually transmitted infections (STIs), M genitalium infection rates can be considerably higher in men who have sex with men, sex workers, and people attending STI clinics,11 but those infected tend to be older than people with other STIs such as chlamydia; 91% of infected men and 67% of infected women are aged 25 to 44 4…”